Global Flow Cytometry Market – Industry Trends and Forecast to 2031

Global Flow Cytometry Market, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceuticals & Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Retail Sales and Direct Tenders) – Industry Trends and Forecast to 2031.

Flow Cytometry Market Analysis and Size

Global flow cytometry market is experiencing robust growth driven by advancements in technology, expanding applications in immunology, oncology, and drug discovery, and increasing demand for personalized medicine. Flow cytometry, a powerful analytical technique, enables the simultaneous analysis of multiple parameters at the single-cell level, providing valuable insights into cellular function and disease mechanisms. Key trends include the integration of artificial intelligence and machine learning algorithms for data analysis, the development of high-through put flow cytometry systems, and the rising adoption of spectral flow cytometry for enhanced multiparametric analysis. As the healthcare industry continues to prioritize precision medicine and biomarker discovery, the global flow cytometry market is poised for further expansion, catering to the growing need for sophisticated cellular analysis tools in research and clinical diagnostics.

Data Bridge Market Research analyses that the global flow cytometry market is expected to reach a value of USD 13.73 billion by 2031 and USD 5.78 billion in 2023, at a CAGR of 11.5% during the forecast period of 2024 to 2031.

Market Definition

Flow cytometry is a powerful analytical technique used in biology and medicine to analyze the physical and chemical characteristics of particles, typically cells or microorganisms, as they flow in a fluid stream through a beam of light. It allows for the simultaneous measurement of multiple parameters of individual cells, such as size, granularity, and fluorescence intensity, providing valuable insights into cellular composition, function, and behavior. Flow cytometry is widely used in research, clinical diagnostics, and drug discovery, enabling scientists and clinicians to study and identify cell populations, investigate disease mechanisms, and develop targeted therapies.

Global Flow Cytometry Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Rising Prevalence of Chronic Diseases

Flow cytometry is a powerful analytical tool used to analyze and quantify single cells or particles in a heterogeneous mixture. It uses lasers and optics to detect and measure cells or particles such as size, shape and fluorescence intensity. This technique involves labeling cells or particles with fluorescent dyes or antibodies that bind to specific cell surface markers or intracellular molecules. The labeled cells or particles are then passed through a flow cytometer, which detects and measures the fluorescence emitted by each cell or particle. Flow cytometry is widely used in many research fields, including immunology, microbiology, stem cell research, cancer research, drug discovery and development, and clinical diagnostics. The technique is constantly evolving with new applications and hardware and software improvements, making it an important tool in the study of biological systems.

• Increase in Use of Flow Cytometry in Drug Discovery

The expanding research activities are projected to drive the growth of flow cytometry. It has emerged as the key to exploring drug discovery and development processes. Due to its outstanding ability to analyze heterogeneous populations of cells, flow cytometry presents an appealing promise for drug discovery and development paths. It delivers higher-resolution insights into the multiparameter functional and biological information of a single cell. Moreover, continuing progress in flow cytometry approaches such as high-throughput multifactorial analysis, cell sorting improvements, and quick event detection and resolution ensures increased efficiency in finding and characterizing novel bioactive medicines.

Opportunity

• Increase in Adoption of Flow Cytometry Techniques in Research and Academia

Flow cytometry is a sophisticated technique for measuring individual cells and other particles in suspension at a rate of thousands of cells per second. Flow cytometry has been extended to environmental investigations, extracellular vesicle analysis, and the capacity to use upwards of 30 different parameters for more extensive analysis. It is most typically used in the setting of immunology. Flow cytometers provide exceptional capabilities, high-quality data, and an easy-to-use platform that saves time for researchers while collecting and evaluating data.

Restraint/Challenge

•   Difficulty in the Development and Validation of Flow Cytometry Assays

Flow cytometry allows multi-parametric analysis of particles per second, and they are often used in basic research, discovery, and pre-clinical and clinical trials. However, flow cytometry-based methods can be difficult to develop and validate due to the lack of standardized cellular reference materials in most cases. They are critical to know what the specific flow cytometry assay can be used for to get appropriate validation to support the study and report. Similarly, there are no guidelines for the validation steps of flow cytometry methods in pre-clinical or clinical trials. Most validation parameters, such as precision and stability, are ignored invalidations, and together the additional relevant parameters should be included for study purpose approaches.

Recent Developments

• In January 2024, Thermo Fisher Scientific Inc. a leading supplier of analytical instruments and life sciences solutions, partnered with The Centre for Molecular and Cellular Platforms (C-CAMP) to establish a Centre of Excellence in Bengaluru. The state-of-the-art facility aims to foster innovation and accelerate breakthroughs in India's growing biotech sector. This collaboration equipped the facility with advanced workflow solutions, driving technological advancements and elevating India's global standing in biotechnology. This initiative aligns with India's projected USD 300 billion bio-economy by 2030, positioning Thermo Fisher Scientific for sustained growth in the thriving Indian biotech market
• In June 2023, BD launched the new robotic BD FACSDuet Premium System to automate sample preparation in clinical flow cytometry, offering enhanced standardization for both IVD and user-defined tests. This system integrates with the BD FACSLyric Flow Cytometry System, streamlining the workflow by reducing manual steps and resource use. The automation allows lab personnel to dedicate more time to sample analysis and interpretation, significantly impacting clinical outcomes. The introduction of this system has positioned BD for growth by meeting critical needs in clinical diagnostics and reinforcing customer trust in their advanced, automated solutions

Global Flow Cytometry Market Scope

Global flow cytometry market is segmented on the basis of product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Reagents and Consumables
• Flow Cytometry Instruments
• Accessories
• Services
• Software

On the basis of product, the global flow cytometry market is segmented into reagents and consumables, flow cytometry instruments, accessories, services, and software.

Technology

• Cell-Based Flow Cytometry
• Bead-Based Flow Cytometry

On the basis of technology, the global flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.

Application

• Research Applications
• Clinical Applications
• Industrial Applications

On the basis of application, the global flow cytometry market is segmented into research applications, clinical applications, and industrial applications.

End User

• Pharmaceuticals & Biotechnology Companies
• Academic & Research Institutes
• Hospitals
• Clinical Testing Laboratories
• Blood Bank
• Others

On the basis of end user, the global flow cytometry market is segmented into pharmaceuticals & biotechnology companies, academic & research institutes, hospitals, clinical testing laboratories, blood bank, and others.

Distribution Channel

• Retail Sales
• Direct Tenders

On the basis of distribution channel, the global flow cytometry market is segmented into retail sales and direct tenders.

Global Flow Cytometry Market Region Analysis/Insights

Global flow cytometry market is analyzed, and market size insights and trends are provided by region, product, technology, application, end user, and distribution channel, as referenced above.

The countries covered in the global flow cytometry market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt and rest of Middle East and Africa.

North America is expected to dominates the global flow cytometry market. U.S. is expected to dominate in North America region due to the boasts a rich ecosystem of research institutions, biotech companies, and academic centers, fostering a culture of innovation and driving advancements in flow cytometry technology. Germany is expected to dominate in Europe region due to robust R&D ecosystem, with renowned universities, research institutes, and biotechnology companies. This environment fosters innovation and facilitates the development of cutting-edge technologies, including flow cytometry systems and related products. China is expected to dominate in Asia-Pacific region due to experiencing rapid economic growth, leading to increased investment in healthcare infrastructure, research, and development and rising healthcare expenditure and a growing focus on personalized medicine are driving the adoption of advanced diagnostic technologies such as flow cytometry.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.       

Competitive Landscape and Global Flow Cytometry Market Share Analysis

Global flow cytometry market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global flow cytometry market.

Some of the major players operating in the global flow cytometry market are Sysmex Corporation, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Sony Biotechnology Inc., Apogee Flow Systems Ltd., Cytek Biosciences, BIOMÉRIEUX, Merck KGaA, Elabscience Bionovation Inc., Miltenyi Biotec, Takara Bio Inc., Thermo Fisher Scientific Inc., Q2 Solutions, CellKraft Biotech Pvt. Ltd., Sartorius AG, NeoGenomics Laboratories, Cell Signaling Technology, Inc., CytoBuoy, ORFLO Technologies, IKEDA SCIENTIFIC Co., Ltd., BioLegend, Inc., Cohorent Corp., Union Biometrica, Inc., Cytonome/ST, LLC, Stratedigm, Inc, NanoCellect Biomedical, BennuBio Inc., Nexcelom Bioscience LLC, On-chip Biotechnologies Co., Ltd. Corporation, and Enzo Biochem Inc, among others.